ARTICLE | Top Story
Onconova, SymBio in cancer deal
July 8, 2011 11:44 PM UTC
Onconova Therapeutics Inc. (Newton, Pa.) granted SymBio Pharmaceuticals Ltd. (Tokyo, Japan) exclusive rights in Japan and Korea to develop and commercialize cancer candidate rigosertib ( ON 01910.Na). Onconova will receive an upfront payment and is eligible for milestones and royalties. Onconova expects Phase I testing to begin in Japan next year. ...